Jeremy Edmunds is an accomplished professional in the field of medicinal chemistry, currently serving as the Executive Director of Immunology Chemistry at AbbVie since July 2019. With a tenure at AbbVie beginning in December 2006, Jeremy has held positions including Director of Immunology Chemistry. Prior to this, Jeremy worked at Pfizer from June 1990 to 2006 as Director of Cardiovascular Chemistry and as a Scientist in Cardiovascular Medicinal Chemistry. Jeremy's educational background includes a Post Doctoral degree in Organic Chemistry from Northwestern University and a PhD in Organic Chemistry, along with a Bachelor of Science degree from Imperial College London.
July, 2019 - present